Professional Documents
Culture Documents
Mientras Se Prueban Tres Vacunas en Humanos, La OMS Alertó Que El Coronavirus Es 10 Veces Más Mortal Que La Gripe A
Mientras Se Prueban Tres Vacunas en Humanos, La OMS Alertó Que El Coronavirus Es 10 Veces Más Mortal Que La Gripe A
11 April 2020
DISCLAIMER:
These landscape documents have been prepared by the World Health Organization (WHO) for information purposes only concerning the 2019-2020
global of the novel coronavirus. Inclusion of any particular product or entity in any of these landscape documents does not constitute, and shall not be
deemed or construed as, any approval or endorsement by WHO of such product or entity (or any of its businesses or activities). While WHO takes
reasonable steps to verify the accuracy of the information presented in these landscape documents, WHO does not make any (and hereby disclaims all)
representations and warranties regarding the accuracy, completeness, fitness for a particular purpose (including any of the aforementioned
purposes), quality, safety, efficacy, merchantability and/or non-infringement of any information provided in these landscape documents and/or of any
of the products referenced therein. WHO also disclaims any and all liability or responsibility whatsoever for any death, disability, injury, suffering, loss,
damage or other prejudice of any kind that may arise from or in connection with the procurement, distribution or use of any product included in any of
these landscape documents.
DNA DNA plasmid Zydus Cadila COVID-19 Pre-Clinical
vaccine
Non- ChAdOx1 University of Oxford COVID-19 Phase 1/2 (not yet MERS, influenza, TB,
Replicating recruiting) Chikungunya, Zika,
Viral Vector NCT04324606 MenB, plague
Non- Ad26 (alone or Janssen Pharmaceutical COVID-19 Pre-Clinical Ebola, HIV, RSV
Replicating with MVA Companies
Viral Vector boost)
DISCLAIMER:
These landscape documents have been prepared by the World Health Organization (WHO) for information purposes only concerning the 2019-2020
global of the novel coronavirus. Inclusion of any particular product or entity in any of these landscape documents does not constitute, and shall not be
deemed or construed as, any approval or endorsement by WHO of such product or entity (or any of its businesses or activities). While WHO takes
reasonable steps to verify the accuracy of the information presented in these landscape documents, WHO does not make any (and hereby disclaims all)
representations and warranties regarding the accuracy, completeness, fitness for a particular purpose (including any of the aforementioned
purposes), quality, safety, efficacy, merchantability and/or non-infringement of any information provided in these landscape documents and/or of any
of the products referenced therein. WHO also disclaims any and all liability or responsibility whatsoever for any death, disability, injury, suffering, loss,
damage or other prejudice of any kind that may arise from or in connection with the procurement, distribution or use of any product included in any of
these landscape documents.
Non- Oral Vaccine Vaxart COVID-19 Pre-Clinical InfA, CHIKV, LASV,
Replicating platform NORV; EBOV, RVF,
Viral Vector HBV, VEE
DISCLAIMER:
These landscape documents have been prepared by the World Health Organization (WHO) for information purposes only concerning the 2019-2020
global of the novel coronavirus. Inclusion of any particular product or entity in any of these landscape documents does not constitute, and shall not be
deemed or construed as, any approval or endorsement by WHO of such product or entity (or any of its businesses or activities). While WHO takes
reasonable steps to verify the accuracy of the information presented in these landscape documents, WHO does not make any (and hereby disclaims all)
representations and warranties regarding the accuracy, completeness, fitness for a particular purpose (including any of the aforementioned
purposes), quality, safety, efficacy, merchantability and/or non-infringement of any information provided in these landscape documents and/or of any
of the products referenced therein. WHO also disclaims any and all liability or responsibility whatsoever for any death, disability, injury, suffering, loss,
damage or other prejudice of any kind that may arise from or in connection with the procurement, distribution or use of any product included in any of
these landscape documents.
Protein Adjuvanted Biological E Ltd COVID-19 Pre-Clinical
Subunit protein subunit
(RBD)
Protein Peptide Flow Pharma Inc COVID-19 Pre-Clinical Ebola, Marburg, HIV,
Subunit Zika, Influenza, HPV
therapeutic vaccine,
BreastCA vaccine
DISCLAIMER:
These landscape documents have been prepared by the World Health Organization (WHO) for information purposes only concerning the 2019-2020
global of the novel coronavirus. Inclusion of any particular product or entity in any of these landscape documents does not constitute, and shall not be
deemed or construed as, any approval or endorsement by WHO of such product or entity (or any of its businesses or activities). While WHO takes
reasonable steps to verify the accuracy of the information presented in these landscape documents, WHO does not make any (and hereby disclaims all)
representations and warranties regarding the accuracy, completeness, fitness for a particular purpose (including any of the aforementioned
purposes), quality, safety, efficacy, merchantability and/or non-infringement of any information provided in these landscape documents and/or of any
of the products referenced therein. WHO also disclaims any and all liability or responsibility whatsoever for any death, disability, injury, suffering, loss,
damage or other prejudice of any kind that may arise from or in connection with the procurement, distribution or use of any product included in any of
these landscape documents.
Protein Recombinant Saint-Petersburg scientific COVID-19 Pre-Clinical
Subunit protein, research institute of
nanoparticles vaccines and serums
(based on S-
protein and
other epitopes)
Protein COVID-19 Innovax/Xiamen COVID-19 Pre-Clinical HPV
Subunit XWG-03 Univ./GSK
truncated S
(spike) proteins
Live Measles Virus DZIF – German Center for COVID-19 Pre-clinical Zika, H7N9, CHIKV
attenuated (S, N targets) Infection Research
virus
DISCLAIMER:
These landscape documents have been prepared by the World Health Organization (WHO) for information purposes only concerning the 2019-2020
global of the novel coronavirus. Inclusion of any particular product or entity in any of these landscape documents does not constitute, and shall not be
deemed or construed as, any approval or endorsement by WHO of such product or entity (or any of its businesses or activities). While WHO takes
reasonable steps to verify the accuracy of the information presented in these landscape documents, WHO does not make any (and hereby disclaims all)
representations and warranties regarding the accuracy, completeness, fitness for a particular purpose (including any of the aforementioned
purposes), quality, safety, efficacy, merchantability and/or non-infringement of any information provided in these landscape documents and/or of any
of the products referenced therein. WHO also disclaims any and all liability or responsibility whatsoever for any death, disability, injury, suffering, loss,
damage or other prejudice of any kind that may arise from or in connection with the procurement, distribution or use of any product included in any of
these landscape documents.
RNA LNP- Fudan University/ COVID-19 Pre-Clinical
encapsulated Shanghai JiaoTong
mRNA cocktail University/RNACure
encoding VLP Biopharma
RNA saRNA Imperial College London COVID-19 Pre-Clinical EBOV; LASV, MARV,
Inf (H7N9), RABV
These landscape documents have been prepared by the World Health Organization (WHO) for information purposes only concerning the 2019-2020
global of the novel coronavirus. Inclusion of any particular product or entity in any of these landscape documents does not constitute, and shall not be
deemed or construed as, any approval or endorsement by WHO of such product or entity (or any of its businesses or activities). While WHO takes
reasonable steps to verify the accuracy of the information presented in these landscape documents, WHO does not make any (and hereby disclaims all)
representations and warranties regarding the accuracy, completeness, fitness for a particular purpose (including any of the aforementioned
purposes), quality, safety, efficacy, merchantability and/or non-infringement of any information provided in these landscape documents and/or of any
of the products referenced therein. WHO also disclaims any and all liability or responsibility whatsoever for any death, disability, injury, suffering, loss,
damage or other prejudice of any kind that may arise from or in connection with the procurement, distribution or use of any product included in any of
these landscape documents.
Unknown Unknown Doherty Institute COVID-19 Pre-Clinical
DISCLAIMER:
These landscape documents have been prepared by the World Health Organization (WHO) for information purposes only concerning the 2019-2020
global of the novel coronavirus. Inclusion of any particular product or entity in any of these landscape documents does not constitute, and shall not be
deemed or construed as, any approval or endorsement by WHO of such product or entity (or any of its businesses or activities). While WHO takes
reasonable steps to verify the accuracy of the information presented in these landscape documents, WHO does not make any (and hereby disclaims all)
representations and warranties regarding the accuracy, completeness, fitness for a particular purpose (including any of the aforementioned
purposes), quality, safety, efficacy, merchantability and/or non-infringement of any information provided in these landscape documents and/or of any
of the products referenced therein. WHO also disclaims any and all liability or responsibility whatsoever for any death, disability, injury, suffering, loss,
damage or other prejudice of any kind that may arise from or in connection with the procurement, distribution or use of any product included in any of
these landscape documents.